TABLE 2.

Perioperative and postoperative characteristics of 544 patients with glioblastoma

Characteristic	Value (%)
GTR	249 (46)
STR	295 (54)
periop death	5(1)
postop motor deficit	35(6)
postop visual deficit	5(1)
postop language deficit	25(5)
adjuvant therapy
Gliadel	203 (37)
temozolomide	159 (29)
BCNU	39(7)
CCNU	24(4)
cisplatin	23(4)
other chemotherapy	95 (17)
radiation therapy	396 (73)
median radiation dose (cGy)	6000 (IQR 5940–6000)
median follow-up duration in mos	10 (IQR6–16)
loss of functional independence	302 (56)
median time to loss of function in mos	10 (IQR 4–19)